Teprotumumab (Tepezza): from the discovery and development of medicines to USFDA approval for active thyroid eye disease (TED) treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
https://link.springer.com/content/pdf/10.1007/s10792-021-01706-3.pdf
Reference80 articles.
1. Wang Y, Smith TJ (2014) Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 55:1735–1748
2. Bahn RS (2010) Graves’ ophthalmopathy. N Engl J Med 362(8):726–738
3. Mellington FE, Dayan CM, Dickinson AJ et al (2017) Management of thyroid eye disease in the United Kingdom: a multicentre thyroid eye disease audit. Orbit 36:159–169
4. Hodgson NM, Rajaii F (2020) Current understanding of the progression and management of thyroid associated orbitopathy: a systematic review. Ophthalmol Ther 9:21–33. https://doi.org/10.1007/s40123-019-00226-9
5. Harris MA, Realini T, Hogg JP, Sivak-Callcott JA (2012) CT dimensions of the lacrimal gland in Graves orbitopathy. Ophthalmic Plast Reconstr Surg 28:69–72
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer – An ACCELERATE Multistakeholder Consensus;Clinical Pharmacology & Therapeutics;2023-11-14
2. Cre-loxP System-Based Mouse Model for Investigating Graves' Disease and Associated Orbitopathy;Thyroid®;2023-11-01
3. Teprotumumab-trbw as a Novel Monoclonal Antibody for Thyroid Eye Disease: A Literature Review;Cureus;2023-08-21
4. Teprotumumab, a Human Monoclonal Antibody Insulin-like Growth Factor-1 Receptor Inhibitor for Thyroid Eye Disease;Clinical Nurse Specialist;2022-05
5. MiR-143 Targets IGF-1R to Suppress Autoimmunity in Thyroid-Associated Ophthalmopathy;Journal of Inflammation Research;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3